Protagonist Therapeutics Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$213,475	$56,368	$7,437	$4,712
Gross Profit	213,475	55,961	7,437	4,712
EBITDA	165,114	2,688	-43,342	-38,978
EBIT		2,281	-43,718	-39,339
Net Income	162,849	3,783	-44,384	-39,339
Net Change In Cash	213,475	56,368	7,437	4,712
Free Cash Flow	218,884	-49,158	-35,529	-2,025
Cash	420,078	193,712	128,390	113,713
Basic Shares	71,007	70,492	63,573	63,772

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$46,016	$434,433	$60,000	$26,581
Gross Profit	44,791	434,433	60,000	26,581
EBITDA	-128,086	280,234	-75,643	-128,004
EBIT	-129,311	279,408	-78,955	-131,373
Net Income	-130,149	275,188	-78,955	-123,413
Net Change In Cash	46,016	434,433	60,000	26,581
Cost of Revenue				2,169
Free Cash Flow	56,081	182,797	-70,845	-108,932
Cash	128,390	97,249	186,727	125,744
Basic Shares	63,573	65,078	56,763	49,042